Cancer cachexia: biomarkers and the influence of age
Molecular Oncology · 27.02.2024
DOI: 10.1002/1878-0261.13590 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Oncology, online erschienen am 27.02.2024. Verfasst von Julia Geppert und 1 weiteren Autor:innen. Beteiligte Einrichtung: Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany. Hauptthemen laut MEDLINE: Cachexia, Neoplasms, Aging. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Helmholtz-Gemeinschaft, European Commission.
Abstract (Originalsprache)
Cancer cachexia (Ccx) is a complex metabolic condition characterized by pronounced muscle and fat wasting, systemic inflammation, weakness and fatigue. Up to 30% of cancer patients succumb directly to Ccx, yet therapies that effectively address this perturbed metabolic state are rare. In recent decades, several characteristics of Ccx have been established in mice and humans, of which we here highlight adipose tissue dysfunction, muscle wasting and systemic inflammation, as they are directly linked to biomarker discovery. To counteract cachexia pathogenesis as early as possible and mitigate its detrimental impact on anti‐cancer treatments, identification and validation of clinically endorsed biomarkers assume paramount importance. Ageing was recently shown to affect both the validity of Ccx biomarkers and Ccx development, but the underlying mechanisms are still unknown. Thus, unravelling the intricate interplay between ageing and Ccx can help to counteract Ccx pathogenesis and tailor diagnostic and treatment strategies to individual needs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Institute for Diabetes and Cancer, Helmholtz Munich, Neuherberg, Germany.
- Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine 1, Heidelberg University Hospital, Germany.
- German Center for Diabetes Research (DZD), Neuherberg, Germany.
ORCID-Profile: Maria Rohm
Förderung
- Helmholtz-Gemeinschaft
- European Commission
Zitieren
APA
Geppert, J., & Rohm, M. (2024). Cancer cachexia: biomarkers and the influence of age. Molecular Oncology. https://doi.org/10.1002/1878-0261.13590
Vancouver
Geppert J, Rohm M. Cancer cachexia: biomarkers and the influence of age. Molecular Oncology. 2024. doi:10.1002/1878-0261.13590
BibTeX
@article{Geppert2024,
author = {Geppert, Julia and Rohm, Maria},
title = {Cancer cachexia: biomarkers and the influence of age},
journal = {Molecular Oncology},
year = {2024},
doi = {10.1002/1878-0261.13590}
}
EUVIMED